Univariate survival analysis (Kaplan-Meier method and log-rank test) revealed that breast cancer patients with low levels of ARF1 expression significantly improved relapse-free survival as compared with high expression levels (Figure 1D), which is likely to be related to its involvement in the lethal and advanced forms of breast cancer. The gene discussed is ARF1; the disease is breast carcinoma.